20
Cdymax India Pharma Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is PAZOPANIB HCL (NON-STERILE DRUG SUBSTANCE), with a corresponding US DMF Number 33054.
Remarkably, this DMF maintains an Active status since its submission on July 28, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 07, 2021, and payment made on July 30, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II